NCT03879512 2024-09-19
Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG
Wuerzburg University Hospital
Phase 1/2 Completed
Clinical Trials
7 trialsNCT05101356 2024-05-21
A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage Adenocarcinoma
University of California, Davis
Phase 1/2 Recruiting
NCT03807102 2023-12-29
TVATLC01
Hunan Province Tumor Hospital
Phase 1/2 Unknown
NCT01290692 2023-07-03
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
TVAX Biomedical
Phase 2 Completed
NCT01081223 2023-06-01
Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
TVAX Biomedical
Phase 1/2 Completed
NCT02035956 2020-01-18
IVAC MUTANOME Phase I Clinical Trial
BioNTech SE
Phase 1 Completed
NCT01702792 2018-04-04
Derivation of Tumor Specific Hybridomas
Dartmouth-Hitchcock Medical Center
Phase 1 Terminated